Bio

Maren Winnick is a Senior Managing Director in the firm’s strategic advisory business focused on the biopharmaceutical sector. Ms. Winnick was most recently the Head of Corporate Finance at Moderna Therapeutics, where she helped lead a $474 million private round financing transaction. Prior to Moderna, she spent 8 years in Investment Banking at Goldman Sachs, both in Capital Markets and Mergers & Acquisitions. While at Goldman Sachs, Ms. Winnick worked on the Healthcare Equity Capital Markets desk, where she raised over $20 billion across 40+ transactions. In the M&A Group, Ms. Winnick advised on a range of healthcare transactions including complex corporate separations and investor activism. Before Goldman Sachs, Ms. Winnick was a Healthcare Consultant at the Monitor Group. Ms. Winnick received a BA from Dartmouth College and an MBA from Columbia Business School.